Reversal of Chemoresistance in Ovarian Cancer by Co-delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform
Journal: The faseb journal (2015)
Institution: University of Chicago
Research Areas: Cancer research
Cell Lines: SKOV3 (Human ovarian cancer line)
Summary: Using time-course holographic imaging studies, this cell cycle arrest followed by progression to apoptosis was clearly visualized and confirmed.